Form 4: Stephen Kraus Reports Transaction in NeueHealth, Inc. Stock
SEC Form 4 Filing
Director Stephen Kraus reports the vesting and disposal of 10,500 restricted stock units of NeueHealth, Inc. on May 13, 2025.
Summary
- On May 15, 2025, Stephen Kraus, a director of NeueHealth, Inc., filed a Form 4 with the SEC.
- The form reports a transaction that occurred on May 13, 2025, involving restricted stock units.
- Specifically, 10,500 restricted stock units vested and were disposed of at a price of $0 per unit.
- Following the transaction, Kraus directly owns 16,444 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects insider activity related to equity compensation.
Key Dates
| Date | Description |
|---|---|
| 05/13/2025 | Date of transaction: Vesting and disposal of restricted stock units. |
| 05/15/2025 | Date of Form 4 filing. |
Keywords
Form 4, NeueHealth, Inc., Stephen Kraus, Restricted Stock Units, Beneficial Ownership, Director, Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.